5 Most Profitable Pharmaceutical Stocks Now

Page 5 of 5

1. Pfizer Inc. (NYSE:PFE)

Trailing Twelve Month Net Income: $31 billion

Number of Hedge Fund Holders in Q3 2022:

Pfizer Inc. (NYSE:PFE) is an American pharmaceutical giant that is one of the oldest companies of its kind after being set up in 1849. It sells medicines and vaccines for a wide variety of diseases such as heart problems, mental health, and liver disorders.

Pfizer Inc. (NYSE:PFE) announced in February 2023 that it will stop trials of a vaccine due to to a breach of guidelines by a third party. As September 2022 ended, 77 of the 920 hedge funds polled by Insider Monkey had invested in the firm.

Pfizer Inc. (NYSE:PFE)’s largest investor is Cliff Asness’ AQR Capital Management which owns 9.8 million shares that are worth $502 million.

Follow Pfizer Inc (NYSE:PFE)

Disclosure: None. You can also take a peek at 25 Most Famous Companies in the World and 10 Hot Healthcare Stocks To Buy Now.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5